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Reply to the Editor:
We appreciate Ricci’s interest in our arti-
cle,1 which describes the application of a
“modified” central cannulation technique2
and open proximal anastomosis technique
for surgical repair of aortic coarctation in
an adult. We understand Ricci’s concern
that circulatory arrest to perform open
proximal anastomosis is not free from com-
plications. Our strategy of cannulation and
cardiopulmonary bypass support for aortic
coarctation in an adult is based on our
previous experience that aortic injury was
caused by crossclamping, in which the por-
tion of coarctation was just distal to the left
subclavian branch. As Ricci mentioned in
his letter, our proposal of this strategy is
based on a single observation; however, it
seems safer to use an open proximal anas-
tomosis technique to avoid possible aortic
injury not only with crossclamping but also
with reliable deep stitches in sufficient
sight.
We recently used the same strategy in
an operation for distal arch and descending
aortic aneurysm. We experienced no tech-
nical or clinical problems; therefore, we
agree with Ricci that this strategy can serve
as a valuable adjunct in patients undergo-
ing complex repairs and reoperations of the
distal arch and descending aorta.3-5
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Mitral valve replacement by a Gore-
Tex reinforced pulmonary autograft
in a child
To the Editor:
We read the interesting case report entitled
“Mitral valve replacement by a Gore-Tex
reinforced pulmonary autograft in a child”
in the October issue of the Journal.1 The
Ross II procedure is not widely used in
cardiac surgical practice because of the
technical difficulties. There are also many
arguments concerning this procedure.2
There might be complications such as con-
striction and deformation on the mitral po-
sition of the pulmonary autograft. There-
fore, lengthwise and crosswise
reinforcements of the pulmonary autografts
might be needed. The procedure is possible
with the use of Dacron or polytetrafluoro-
ethylene (Gore-Tex; W. L. Gore & Asso-
ciates, Inc, Flagstaff, Ariz) grafts.
For pediatric patients with a small mi-
tral annulus, the Ross II procedure is indi-
cated. We performed the Ross II procedure
in a child with congenital mitral insuffi-
ciency and endocarditis. The mitral leaflets
were totally deformed, so we resected
them. The mitral annulus was 14 mm in
diameter. We decided to replace the mitral
valve with a pulmonary autograft because
of the endocarditis and the absence of an
adequately sized mechanical mitral valve
prosthesis. After the pulmonary autograft
was harvested, it was introduced into the
14-mm diameter soft Dacron tube graft by
the same method that the authors used.
Because the left atrium was very large, a
Dacron graft carrying the pulmonary au-
tograft was sutured to the mitral annulus by
using the “top hat” technique.3 However,
perioperative transesophageal echocardiog-
raphy performed after cardiopulmonary by-
pass revealed a 25 mm Hg transmitral gra-
dient. We decided to reinstitute
cardiopulmonary bypass and reevaluate the
composite pulmonary autograft. After car-
dioplegic arrest, the left atrium was re-
opened, and the Dacron graft was found to
be constricted and deformed. Therefore the
Dacron graft was replaced with a 14-mm
diameter polytetrafluoroethylene (Gore-
Tex) tube graft. This time there was no
significant transmitral gradient.
We believe that stiff Dacron grafts used
for the reinforcement of pulmonary au-
tografts may yield better results than soft
ones. We recommend the use of polytetra-
fluoroethylene (Gore-Tex) tube grafts in
the Ross II procedure instead of the Dacron
grafts that Yamagushi and colleagues1
used.
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Reply to the Editor:
My colleagues and I appreciate the
thoughtful comments of Dr Tireli. In chil-
dren, the top hat method1 is limited to
selected patients with a large left atrium.
The implanted graft, which over-protrudes
into the left atrium, carries a risk of pulmo-
nary venous obstruction and may impair
the reservoir effect of the left atrium. The
top hat method is relatively easy during the
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Ross II operation, because the left ventric-
ular end of the graft can be used as a
margin for suturing to the mitral annulus. A
sewing cuff around the graft is unneces-
sary. However, stronger lengthwise rein-
forcement is essential to maintain the shape
of the autograft. It seems to me that the
pulmonary autograft flattened out in Dr
Tireli’s patient, and that the consequent left
ventricular inflow obstruction caused pul-
monary congestion because the lengthwise
reinforcement of the pulmonary autograft
failed. A semi-flexible Dacron graft is
probably an inappropriate choice of mate-
rial for the external cylinder of the pulmo-
nary autograft in pediatric patients. A semi-
rigid graft designed to resist elongation
both lengthwise and crosswise is more suit-
able for reinforcing the pulmonary au-
tograft. At present, I believe that a non-
stretch-type polytetrafluoroethylene graft
(Gore-Tex; W. L. Gore & Associates, Inc,
Flagstaff, Ariz) is the best material. Be-
cause the left ventricular end (the pulmo-
nary commissure end) of the graft is anas-
tomosed to the mitral annulus in the top hat
method, varus deformity of the pulmonary
commissures and subsequent narrowing of
the orifice are prevented. If the left atrial
end of the graft (the pulmonary annular
end) is anastomosed to the mitral annulus,
left ventricular outflow obstruction is infal-
lible, because the implanted graft protrudes
into the left ventricle. In addition, varus
deformity of the pulmonary commissures
because of the left ventricular inner pres-
sure is infallible in the absence of a rigid
commissural stent.
A great advantage of our technique,2 in
which a sewing cuff made of a polytetra-
fluoroethylene felt is anastomosed to the
middle portion of the polytetrafluoroethyl-
ene (Gore-Tex) graft, is that neither end of
the graft protrudes into the left atrium or
the left ventricle. Furthermore, because of
the sewing cuff, the polytetrafluoroethyl-
ene (Gore-Tex) graft is fairly close to the
left ventricular end (the pulmonary com-
missure end) of the graft and is tightly
anastomosed to the mitral annulus. There-
fore, varus deformity of the pulmonary
commissure is prevented in the absence of
a rigid stent. The polytetrafluoroethylene
(Gore-Tex) external cylinder ensures an
adequate neo-mitral orifice.
In conclusion, although there are some
technical difficulties, I believe that the
Ross II operation is a useful surgical option
for pediatric patients with a narrow mitral
annulus. With our technique, the Ross II
operation is suitable for infants with a nar-
row left atrium or atrioventricular septal
defect and left ventricular outflow obstruc-
tion.
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Intraoperative hematocrit and
cardiopulmonary bypass
To the Editor:
I read with interest the article by Habib and
associates1 in the June issue of the Journal
concerning the role of the lowest hemato-
crit as the predictor variable on early and
late postoperative outcomes. It is important
to maintain the hematocrit within the nor-
mal range and avoid extremes. The mere
effect of such a strong association begs for
a prospective randomized study, as stated
by the authors. However, their discussion
and conclusion based on the large number
of retrospective patients are incomplete. In
the field of cardiovascular epidemiology,
anemia occurs in 15% to 55% of patients
with chronic heart failure.2 However, it is
unknown whether a strong association of
anemia and heart failure has any temporal
and causal relation, that is, whether anemia
precedes and leads to heart failure.
Nonetheless, the authors do not mention
the characteristics and prevalence of heart
failure in the baseline data. An argument
for expanded plasma volume occurring in
acute heart failure, seen in decompensated
heart failure, might contribute to low he-
moglobin concentrations. Such a feature is
not uncommon in patients undergoing non-
percutaneous transluminal coronary angio-
plasty in our era.
It would seem intuitive to deduct that
patients who undergo off-pump cardiac by-
pass surgery with minimal blood loss have
less activation of the inflammatory cascade
from the bypass circuit and do better. How-
ever, given the already available data from
randomized trials, no difference exists be-
tween the 2.3 This suggests a minimal role
for the intraoperative spectrum of hemato-
crit in off-pump surgery. Another impor-
tant question that was not answered was
whether aprotinin was given consistently,
because this drug can also modify patients’
outcomes.4
Habib and colleagues1 gave no informa-
tion about the mean number of grafts per
patient, perioperative blood loss, blood-
saving techniques, and “transfusion trig-
ger.” These issues are important because
there is a dose-dependent association be-
tween blood transfusion and the develop-
ment of severe postoperative infection and
death in patients undergoing cardiac sur-
gery.5
Despite this omission, the overall in-
hospital mortality rate is slightly higher
than that reported for a similar series of
2,569 patients undergoing coronary artery
bypass grafting in whom the “transfusion
trigger” during cardiopulmonary bypass
(CPB) was a packed-cell volume of less
than 20% and mortality was defined as
death during the hospital stay or within 30
days of surgery (3.6% vs 2.79%).5
Was the pump primed with blood? Ad-
ministration of blood during CPB may be-
gin a cascade of events that contributes to
postoperative. Thus, whenever possible,
preoperative pharmacologic therapy, but
not transfusional, treatment of anemia
should be used.
Also, the authors probe the data to de-
termine any association of anemia and late
mortality. It is interesting that the authors
do not report the reason for patient death.
Because the case mix of death is important,
if cardiovascular death was the cause, did
any of the patients who received more
blood or had the lowest hematocrit have a
lower graft patency in the short and long
term?
Finally, according to the range of abso-
lute differences in the perioperative hemat-
ocrit shown in Table 1 of the article
(difference between preoperative and post-
operative CPB hematocrits; range 12%-
15.2%), it would seem more reasonable to
use this parameter than individual values if
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